Amphotericin B-induced oxidative damage and killing of Candida albicans
- PMID: 3519792
- DOI: 10.1093/infdis/154.1.76
Amphotericin B-induced oxidative damage and killing of Candida albicans
Abstract
Amphotericin B (AmB) is known to bind to ergosterol in fungal cell membranes, but the precise mechanism of its toxicity to cells is as yet poorly understood. AmB autooxidizes, and it is possible that its antifungal effects could result from oxidative damage. Exposure of protoplasts of Candida albicans to AmB under hypoxic conditions reduced protoplast lysis by as much as 80% compared with incubations in air. Protoplasts were protected from AmB-induced lysis by exogenous catalase and/or superoxide dismutase (SOD). Whole cells of C. albicans were protected by exogenous catalase from AmB-induced leakage of [3H]leucine and from killing by AmB. Cells grown on medium inducing high levels of endogenous catalase were resistant to AmB-induced growth inhibition. In contrast, AmB-induced K+ leakage was not hindered under hypoxic conditions or in the presence of catalase or SOD. Thus the lethal and lytic effects of AmB on C. albicans cells and protoplasts, but not prelethal AmB-induced K+ leakage, are mediated by oxidative damage.
Similar articles
-
Role of cell defense against oxidative damage in the resistance of Candida albicans to the killing effect of amphotericin B.Antimicrob Agents Chemother. 1988 May;32(5):702-5. doi: 10.1128/AAC.32.5.702. Antimicrob Agents Chemother. 1988. PMID: 3293525 Free PMC article.
-
Enhancement of amphotericin B activity against Candida albicans by superoxide radical.Mycopathologia. 2004 Jul;158(1):9-15. doi: 10.1023/b:myco.0000038430.20669.80. Mycopathologia. 2004. PMID: 15487314
-
ROS formation is a differential contributory factor to the fungicidal action of Amphotericin B and Micafungin in Candida albicans.Int J Med Microbiol. 2017 Jun;307(4-5):241-248. doi: 10.1016/j.ijmm.2017.03.005. Epub 2017 Apr 4. Int J Med Microbiol. 2017. PMID: 28412040
-
Emerging Role of Sphingolipids in Amphotericin B Drug Resistance.Microb Drug Resist. 2023 Aug;29(8):319-332. doi: 10.1089/mdr.2022.0353. Epub 2023 Jun 15. Microb Drug Resist. 2023. PMID: 37327022 Review.
-
Nature and development of phenotypic resistance to amphotericin B in Candida albicans.Adv Microb Physiol. 1986;27:277-320. doi: 10.1016/s0065-2911(08)60307-0. Adv Microb Physiol. 1986. PMID: 3532717 Review. No abstract available.
Cited by
-
Inhibition of Dermatophyte Fungi by Australian Jarrah Honey.Pathogens. 2021 Feb 11;10(2):194. doi: 10.3390/pathogens10020194. Pathogens. 2021. PMID: 33670403 Free PMC article.
-
Identification and characterization of catA, a mutation causing catalase deficiency in Dictyostelium discoideum.J Bacteriol. 1989 Mar;171(3):1492-5. doi: 10.1128/jb.171.3.1492-1495.1989. J Bacteriol. 1989. PMID: 2921242 Free PMC article.
-
Susceptibility profiles of amphotericin B and posaconazole against clinically relevant mucorales species under hypoxic conditions.Antimicrob Agents Chemother. 2015 Feb;59(2):1344-6. doi: 10.1128/AAC.04424-14. Epub 2014 Dec 1. Antimicrob Agents Chemother. 2015. PMID: 25451049 Free PMC article.
-
Amphotericin B protects cis-parinaric acid against peroxyl radical-induced oxidation: amphotericin B as an antioxidant.Antimicrob Agents Chemother. 1997 Apr;41(4):743-7. doi: 10.1128/AAC.41.4.743. Antimicrob Agents Chemother. 1997. PMID: 9087481 Free PMC article.
-
Advancing fungal keratitis treatment: transitioning from conventional amphotericin B therapy to nanocarrier-based delivery systems.Naunyn Schmiedebergs Arch Pharmacol. 2025 May 17. doi: 10.1007/s00210-025-04268-8. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40381011 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources